SCHEMBL2808212

SCHEMBL2808212

Clc1ccccc1CN1CCN(c2nc3c4c(n[nH]c4n2)CCN3Cc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.47
ALDH1A1 P00352 6/20 0.45
KDM4E B2RXH2 5/20 0.45
HTT P42858 1/20 0.45
CLPP Q16740 1/20 0.43
PLA2G1B P04054 1/20 0.43
RAB9A P51151 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
MAPT P10636 4/20 0.42
TP53 P04637 1/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TNKS O95271 1/20 0.40
PARP1 P09874 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
ATM Q13315 1/20 0.39
FAAH O00519 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13168897 0.90 LMNA (0.41) ALDH1A1KDM4EHTTCLPPRAB9A
SCHEMBL2812035 0.90 POLB (0.47) ALDH1A1KDM4EHTTCLPPMAPT
SCHEMBL2810794 0.86 GAA (0.45) ALDH1A1KDM4EHTTMAPTTP53
SCHEMBL2812360 0.86 DRD4 (0.43) ALDH1A1KDM4EHTTMAPTGAA
SCHEMBL2809499 0.85 HTR6 (0.46) ALDH1A1KDM4EHTTGAA
SCHEMBL2809641 0.85 ALDH1A1 (0.44) ALDH1A1KDM4EKMT2AGAA
SCHEMBL2812038 0.85 BRS3 (0.44) GAACASP1CASP5
SCHEMBL2811974 0.85 GAA (0.36) ALDH1A1KDM4EHTTMAPTGAA
SCHEMBL2810536 0.84 HTR2A (0.48) ALDH1A1KDM4EHTTMAPTTP53
SCHEMBL2810576 0.84 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTGAATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 SIGMAR1 4535/4885ALDH1A1 924/4885KDM4E 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.